Joint clinical and socio-demographic determinants of CD4 cell count and body weight in HIV/TB co-infected adult patients on HAART

被引:2
|
作者
Birhan, Hailegebrael [1 ]
Seyoum, Awoke [2 ]
Derebe, Kenaw [1 ]
Muche, Setegn [1 ]
Wale, Mitiku [1 ]
Sisay, Solomon [1 ]
机构
[1] Debre Tabor Univ, Coll Nat & Computat Sci, Dept Stat, Debre Tabor, Ethiopia
[2] Bahir Dar Univ, Coll Sci, Dept Stat, Bahir Dar, Ethiopia
关键词
CD4 cell count; HIV; TB co-infection; Joint modeling; Linear mixed model; Weight; TUBERCULOSIS; SURVIVAL; TIME; PREDICTORS; HIV/AIDS; SEPARATE; AFRICA; BURDEN; MODELS;
D O I
10.1016/j.sciaf.2022.e01396
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Tuberculosis is one of the most lethal communicable diseases in the world. In tuberculosis patients, HIV speeds up the course of the infection from latent to active ill-ness. This study aimed to identify joint clinical and socio demographic determinant factors of CD4+ cell count and body weight in HIV/TB co-infected adult patients.Methods: From January 2013 to December 2019, 374 HIV/TB co-infected individuals were treated and had follow-ups. This study used descriptive data analysis, a linear mixed effects model for longitudinal data, and joint modeling of the two longitudinal outcome variables.Results: In this study, 51.1% of the 374 HIV-TB co-infected patients were women, 47.1% were rural dwellers, and 71.9% developed extra pulmonary TB. Females made up 54.3% of all patients who died. To detect the presence of correlation among repeated measured data, the AR (1) structure was chosen. The joint model was more appropriate for analysing and interpreting current data.Conclusions: Baseline age, follow-up time, baseline weight, place of residence, adherence level, educational background, functional status, WHO clinical stage, smoking status and type of TB developed were identified as significant joint factors in CD4 cell count and weight of HIV/TB co-infected patients from potential joint predictor variables. Therefore, the concerned bodies, specifically the FMOH and regional health staffs, should enhance public awareness about the factors that lead to a drop in CD4 count and weight gain, as well as an increased risk of death from HIV/TB co-infection. Furthermore, special attention should be paid to women and patients with poor adherence. Medication and treatment must be affordable and accessible to all co-infected patients in order to maximize their CD4 count and proportional body weight to their height, and to lengthen the lives of indi-viduals who are co-infected. (c) 2022 The Authors. Published by Elsevier B.V. on behalf of African Institute of Mathematical Sciences / Next Einstein Initiative.This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Association between depressive symptoms, CD4 count and HIV viral suppression among HIV-HCV co-infected people
    Aibibula, Wusiman
    Cox, Joseph
    Hamelin, Anne-Marie
    Moodie, Erica E. M.
    Anema, Aranka
    Klein, MarinaB
    Brassard, Paul
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2018, 30 (05): : 643 - 649
  • [22] Nadir CD4 Cell Count Predicts Neurocognitive Impairment in HIV-Infected Patients
    Munoz-Moreno, Jose A.
    Fumaz, Carmina R.
    Ferrer, Maria J.
    Prats, Anna
    Negredo, Eugenia
    Garolera, Maite
    Perez-Alvarez, Nuria
    Molto, Jose
    Gomez, Guadalupe
    Clotet, Bonaventura
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 (10) : 1301 - 1307
  • [23] The impact of adherence on CD4 cell count responses among HIV-infected patients
    Wood, E
    Hogg, RS
    Yip, B
    Harrigan, PR
    O'Shaughnessy, JV
    Montaner, JSG
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 35 (03) : 261 - 268
  • [24] Is the CD4 cell percentage a better marker of immunosuppression than the absolute CD4 cell count in HIV-infected patients with cirrhosis?
    Bongiovanni, Marco
    Gori, Andrea
    Lepri, Alessandro Cozzi
    Antinori, Andrea
    de Luca, Andrea
    Pagano, Gabriella
    Chiodera, Alessandro
    Puoti, Massimo
    Monforte, Antonella d'Arminio
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 45 (05) : 650 - 653
  • [25] Analysis of treatment for HIV-infected patients considering CD4 T cell count in STI
    Park, Ki Yeon
    Chung, Han Byul
    Chung, Chung Choo
    [J]. 2006 SICE-ICASE INTERNATIONAL JOINT CONFERENCE, VOLS 1-13, 2006, : 3382 - +
  • [26] Cryptococcal antigenemia in HIV infected patients with a CD4 count ≤ 100 cell mm-3
    Linares, L.
    Paz, J.
    Bustamante, B.
    [J]. MYCOSES, 2012, 55 : 206 - 207
  • [27] Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count >350 X 106/l
    Opravil, M
    Ledergerber, B
    Furrer, H
    Hirschel, B
    Imhof, A
    Gallant, S
    Wagels, T
    Bernasconi, E
    Meienberg, F
    Rickenbach, M
    Weber, R
    [J]. AIDS, 2002, 16 (10) : 1371 - 1381
  • [28] Modelling CD4 T Cell Recovery in Hepatitis C and HIV Co-infected Children Receiving Antiretroviral Therapy
    Majekodunmi, Adedeji O.
    Thorne, Claire
    Malyuta, Ruslan
    Volokha, Alla
    Callard, Robin E.
    Klein, Nigel J.
    Lewis, Joanna
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2017, 36 (05) : E123 - E129
  • [29] Oral candidiasis as a clinical marker related to viral load, CD4 lymphocyte count and CD4 lymphocyte percentage in HIV-infected patients
    Campo, J
    Del Romero, J
    Castilla, J
    García, S
    Rodríguez, C
    Bascones, A
    [J]. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2002, 31 (01) : 5 - 10
  • [30] Genotype 3 HCV infection, lower CD4 cell count and higher liver stiffness are related with bone mineral reduction in HIV/HCV co-infected patients (MASTER cohort)
    Nasta, P.
    Spinetti, A.
    Urbinati, L.
    Lanza, P.
    Maggiolo, F.
    Gagliardini, R.
    Segala, D.
    Blanc, P.
    Ladisa, N.
    Zacchi, F.
    Castelli, F.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2015, 22 : 26 - 26